• 1
    Gottwein J.M., Scheel T.K., Jensen T.B., Lademann J.B., Prentoe J.C., Knudsen M.L., Hoegh A.M., Bukh J. ( 2009) Development and characterization of hepatitis C virus genotype 1–7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs. Hepatology 49: 36477.
  • 2
    Smith D.B., Bukh J., Kuiken C., Muerhoff A.S., Rice C.M., Stapleton J.T., Simmonds P. ( 2013) Expanded classification of hepatitis C Virus into 7 genotypes and 67 Subtypes: updated criteria and assignment web resource. Hepatology 59: 31827.
  • 3
    Moradpour D., Penin F., Rice C.M. ( 2007) Replication of hepatitis C virus. Nat Rev Microbiol 5: 4536.
  • 4
    Shoji I., Deng L., Hotta H. ( 2011) Molecular mechanism of hepatitis C virus-induced glucose metabolic disorders. Front Microbiol 2: 278.
  • 5
    Arzumanyan A., Reis H.M., Feitelson M.A. ( 2013) Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma. Nat Rev Cancer 13: 12335.
  • 6
    Shepard C.W., Finelli L., Alter M.J. ( 2005) Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5: 55867.
  • 7
    Mohd Hanafiah K., Groeger J., Flaxman A.D., Wiersma S.T. ( 2013) Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 57: 133342.
  • 8
    Calland N., Dubuisson J., Rouille Y., Seron K. ( 2012) Hepatitis C virus and natural compounds: a new antiviral approach? Viruses 4: 2197217.
  • 9
    Ploss A., Dubuisson J. ( 2012) New advances in the molecular biology of hepatitis C virus infection: towards the identification of new treatment targets. Gut 61 (Suppl 1): i2535.
  • 10
    Stickel F., Schuppan D. ( 2007) Herbal medicine in the treatment of liver diseases. DigLiver Dis 39: 293304.
  • 11
    Asl M.N., Hosseinzadeh H. ( 2008) Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds. Phytother Res 22: 70924.
  • 12
    Pompei R., Flore O., Marccialis M.A., Pani A., Loddo B. ( 1979) Glycyrrhizic acid inhibits virus growth and inactivates virus particles. Nature 281: 68990.
  • 13
    Cinatl J., Morgenstern B., Bauer G., Chandra P., Rabenau H., Doerr H.W. ( 2003) Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet 361: 20456.
  • 14
    Fiore C., Eisenhut M., Krausse R., Ragazzi E., Pellati D., Armanini D., Bielenberg J. ( 2008) Antiviral effects of Glycyrrhiza species. Phytother Res 22: 1418.
  • 15
    Wang J., Chen X., Wang W., Zhang Y., Yang Z., Jin Y., Ge H.M., Li E., Yang G. ( 2013) Glycyrrhizic acid as the antiviral component of Glycyrrhiza uralensis Fisch. against coxsackievirus A16 and enterovirus 71 of hand foot and mouth disease. J Ethnopharmacol 147: 11421.
  • 16
    van Rossum T.G., Vulto A.G., Hop W.C., Brouwer J.T., Niesters H.G., Schalm S.W. ( 1999) Intravenous glycyrrhizin for the treatment of chronic hepatitis C: a double-blind, randomized, placebo-controlled phase I/II trial. J Gastroenterol Hepatol 14: 10939.
  • 17
    Orlent H., Hansen B.E., Willems M., Brouwer J.T., Huber R., Kullak-Ublick G.A., Gerken G., Zeuzem S., Nevens F., Tielemans W.C., Zondervan P.E., Lagging M., Westin J., Schalm S.W. ( 2006) Biochemical and histological effects of 26 weeks of glycyrrhizin treatment in chronic hepatitis C: a randomized phase II trial. J Hepatol 45: 53946.
  • 18
    Korenaga M., Hidaka I., Nishina S., Sakai A., Shinozaki A., Gondo T., Furutani T., Kawano H., Sakaida I., Hino K. ( 2011) A glycyrrhizin-containing preparation reduces hepatic steatosis induced by hepatitis C virus protein and iron in mice. Liver Int 31: 55260.
  • 19
    Ashfaq U.A., Masoud M.S., Nawaz Z., Riazuddin S. ( 2011) Glycyrrhizin as antiviral agent against hepatitis C virus. J Transl Med 9: 112.
  • 20
    Matsumoto Y., Matsuura T., Aoyagi H., Matsuda M., Hmwe S.S., Date T., Watanabe N., Watashi K., Suzuki R., Ichinose S., Wake K., Suzuki T., Miyamura T., Wakita T., Aizaki H. ( 2013) Antiviral activity of glycyrrhizin against hepatitis C virus in vitro. PLoS ONE 8: e68992.
  • 21
    Lindenbach B.D., Evans M.J., Syder A.J., Wolk B., Tellinghuisen T.L., Liu C.C., Maruyama T., Hynes R.O., Burton D.R., McKeating J.A., Rice C.M. ( 2005) Complete replication of hepatitis C virus in cell culture. Science 309: 6236.
  • 22
    Bungyoku Y., Shoji I., Makine T., Adachi T., Hayashida K., Nagano-Fujii M., Ide Y., Deng L., Hotta H. ( 2009) Efficient production of infectious hepatitis C virus with adaptive mutations in cultured hepatoma cells. J Gen Virol 90: 16819.
  • 23
    Li S.Y., Fuchino H., Kawahara N., Sekita S., Satake M. ( 2002) New phenolic constituents from Smilax bracteata. J Nat Prod 65: 2626.
  • 24
    Fuchino H., Sekita S., Mori K., Kawahara N., Satake M., Kiuchi F. ( 2008) A new leishmanicidal saponin from Brunfelsia grandiflora. Chem Pharm Bull 56: 936.
  • 25
    Fuchino H., Kawano M., Mori-Yasumoto K., Sekita S., Satake M., Ishikawa T., Kiuchi F., Kawahara N. ( 2010) In vitro leishmanicidal activity of benzophenanthridine alkaloids from Bocconia pearcei and related compounds. Chem Pharm Bull 58: 104750.
  • 26
    Fuchino H., Daikonya A., Kumagai T., Goda Y., Takahashi Y., Kawahara N. ( 2013) Two new labdane diterpenes from fresh leaves of Leonurus japonicus and their degradation during drying. Chem Pharm Bull 61: 497503.
  • 27
    Deng L., Adachi T., Kitayama K., Bungyoku Y., Kitazawa S., Ishido S., Shoji I., Hotta H. ( 2008) Hepatitis C virus infection induces apoptosis through a Bax-triggered, mitochondrion-mediated, caspase 3-dependent pathway. J Virol 82: 103758.
  • 28
    Deng L., Shoji I., Ogawa W., Kaneda S., Soga T., Jiang D.P., Ide Y.H., Hotta H. ( 2011) Hepatitis C virus infection promotes hepatic gluconeogenesis through an NS5A-mediated, FoxO1-dependent pathway. J Virol 85: 855668.
  • 29
    Wahyuni T.S., Tumewu L., Permanasari A.A., Apriani E., Adianti M., Rahman A., Widyawaruyanti A., Lusida M.I., Fuad A., Soetjipto D., Nasronudin D., Fuchino H., Kawahara N., Shoji I., Deng L., Aoki C., Hotta H. ( 2013) Antiviral activities of Indonesian medicinal plants in the East Java region against hepatitis C virus. Virol J 10: 259.
  • 30
    Demizu S., Kajiyama K., Takahashi K., Hiraga Y., Yamamoto S., Tamura Y., Okada K., Kinoshita T. ( 1988) Antioxidant and antimicrobial constituents of licorice: isolation and structure elucidation of a new benzofuran derivative. Chem Pharm Bull 36: 34749.
  • 31
    Kinoshita T., Saitoh T., Shibata S. ( 1978) A new 3-arylcoumarin from licorice root. Chem Pharm Bull 26: 13540.
  • 32
    Shiozawa T., Urata S., Kinoshita T., Saitoh T. ( 1989) Revised structures of glycyrol and isoglycyrol, constituents of the root of Glycyrrhiza uralensis. Chem Pharm Bull 37: 223940.
  • 33
    Chokchaisiri R., Suaisom C., Sriphota S., Chindaduang A., Chuprajob T., Suksamrarn A. ( 2009) Bioactive flavonoids of the flowers of Butea monosperma. Chem Pharm Bull 57: 42832.
  • 34
    Kondo K., Shiba M., Nakamura R., Morota T., Shoyama Y. ( 2007) Constituent properties of licorices derived from Glycyrrhiza uralensis, G. glabra, or G. inflata identified by genetic information. Biol Pharm Bull 30: 12717.
  • 35
    Sekine-Osajima Y., Sakamoto N., Nakagawa M., Itsui Y., Tasaka M., Nishimura-Sakurai Y., Chen C.H., Suda G., Mishima K., Onuki Y., Yamamoto M., Maekawa S., Enomoto N., Kanai T., Tsuchiya K., Watanabe M. ( 2009) Two flavonoids extracts from Glycyrrhizae radix inhibit in vitro hepatitis C virus replication. Hepatol Res 39: 609.
  • 36
    Mae T., Kishida H., Nishiyama T., Tsukagawa M., Konishi E., Kuroda M., Mimaki Y., Sashida Y., Takahashi K., Kawada T., Nakagawa K., Kitahara M. ( 2003) A licorice ethanolic extract with peroxisome proliferator-activated receptor-gamma ligand-binding activity affects diabetes in KK-Ay mice, abdominal obesity in diet-induced obese C57BL mice and hypertension in spontaneously hypertensive rats. J Nutr 133: 336977.
  • 37
    Kuroda M., Mimaki Y., Sashida Y., Mae T., Kishida H., Nishiyama T., Tsukagawa M., Konishi E., Takahashi K., Kawada T., Nakagawa K., Kitahara M. ( 2003) Phenolics with PPAR-gamma ligand-binding activity obtained from licorice (Glycyrrhiza uralensis roots) and ameliorative effects of glycyrin on genetically diabetic KK-A(y) mice. Bioorg Med Chem Lett 13: 426772.
  • 38
    Tanaka Y., Kikuzaki H., Fukuda S., Nakatani N. ( 2001) Antibacterial compounds of licorice against upper airway respiratory tract pathogens. J Nutr Sci Vitaminol 47: 2703.
  • 39
    Peng L., Qi Y., Wu H., Wei Q. ( 2011) Interaction of glycyrol with calcineurin A studied by spectroscopic methods and docking. IUBMB Life 63: 1420.
  • 40
    Shin E.M., Zhou H.Y., Guo L.Y., Kim J.A., Lee S.H., Merfort I., Kang S.S., Kim H.S., Kim S., Kim Y.S. ( 2008) Anti-inflammatory effects of glycyrol isolated from Glycyrrhiza uralensis in LPS-stimulated RAW264. 7 macrophages. Int Immunopharmacol 8: 152432.